Science Explorer Interactive view Map
Company · Wilmington · United States

AstraZeneca (United States)

In research, AstraZeneca (United States) stands highest in Medicine (#1,070 of 10,443 worldwide), Health Sciences (#1,478 of 11,982 worldwide) and Life Sciences (#1,138 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology, Immunology and Pulmonary and Respiratory Medicine — Oncology is 10.0× its share of world research.

astrazeneca-us.com/homeROR OpenAlex
World rank, 2022–2025
#2,368
of 28,054 · #2,917 all time
Rank in United States
#362
of 4,192
Research works
3k
▲ 31% vs 2013–17
Citations
93k
31.4 per fractional work
Top-10% rate
20.6%
record average 16.5%
Open access
46%
world 28%

What is AstraZeneca (United States) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #1,070 of 10,443 19.1%433 #967
Health SciencesDomain #1,478 of 11,982 19.1%448 #1255
Life SciencesDomain #1,138 of 7,800 24.0%184 #1624
Pulmonary and Respiratory MedicineSubfield #445 of 1,144 16.7%84 #733
Biochemistry, Genetics and Molecular BiologyField #1,564 of 3,579 25.0%125 #1806
OncologySubfield #413 of 772 20.1%81 #581
Molecular BiologySubfield #1,210 of 2,175 26.7%80 #1384

Each strip is that field’s whole ranked pool, with the notch where AstraZeneca (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Medicine#967 #1,070
  2. Health Sciences#1,255 #1,478
  3. Life Sciences#1,624 #1,138
  4. Pulmonary and Respiratory Medicine#733 #445
  5. Biochemistry, Genetics and Molecular Biology#1,806 #1,564
  6. Oncology#581 #413
  7. Molecular Biology#1,384 #1,210
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does AstraZeneca (United States) specialise in?

Where its research is concentrated relative to its size: Oncology takes 10.0× the share of its output that it takes of world research.

  1. OncologySubfield · 80.7 works10.0×
  2. ImmunologySubfield · 38.8 works7.8×
  3. Pulmonary and Respiratory MedicineSubfield · 83.8 works7.6×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.13× its world share, 4 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.26× its world share, 125 worksBiochemistry, Geneti…Immunology and Microbiology: 5.46× its world share, 40 worksImmunology and Micro…Neuroscience: 0.27× its world share, 3 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.72× its world share, 12 worksPharmacology, Toxico…Chemical Engineering: 0.09× its world share, 0 worksChemical EngineeringChemistry: 1.10× its world share, 12 worksChemistryComputer Science: 0.22× its world share, 12 worksComputer ScienceEarth and Planetary Sciences: 0.02× its world share, 0 worksEarth and Planetary …Energy: 0.09× its world share, 1 worksEnergyEngineering: 0.12× its world share, 12 worksEngineeringEnvironmental Science: 0.16× its world share, 6 worksEnvironmental ScienceMaterials Science: 0.18× its world share, 4 worksMaterials ScienceMathematics: 1.23× its world share, 10 worksMathematicsPhysics and Astronomy: 0.02× its world share, 0 worksPhysics and AstronomyDentistry: 0.10× its world share, 0 worksDentistryHealth Professions: 0.60× its world share, 11 worksHealth ProfessionsMedicine: 3.13× its world share, 433 worksMedicineNursing: 0.71× its world share, 2 worksNursingVeterinary: 1.26× its world share, 1 worksVeterinaryBusiness, Management and Accounting: 0.01× its world share, 0 worksBusiness, Management…Decision Sciences: 0.29× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 1.20× its world share, 18 worksEconomics, Econometr…Psychology: 0.11× its world share, 2 worksPsychologySocial Sciences: 0.05× its world share, 4 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.5×. Every wedge is a field page.

Who are the top researchers at AstraZeneca (United States)?

Ranked on the composite score, Gene Colice, Zhongwu Lai and J. Carl Barrett lead among researchers whose main affiliation is AstraZeneca (United States).

  1. 1 Gene Colice United States · #34,256 worldwide 258 citations · 49 works
  2. 2 Zhongwu Lai United States · #39,991 worldwide 738 citations · 32 works
  3. 3 J. Carl Barrett United States · #47,476 worldwide 501 citations · 68 works
  4. 4 Brian Dougherty United States · #60,131 worldwide 506 citations · 29 works
  5. 5 Dean G. Brown United States · #200,733 worldwide 438 citations · 17 works
  6. 6 Wright W. Nichols United States · #204,300 worldwide 237 citations · 20 works
  7. 7 Raj Tummala United States · #230,137 worldwide 178 citations · 21 works
  8. 8 David W. Boulton United States · #238,061 worldwide 124 citations · 32 works
  9. 9 Trung N. Tran United States · #239,352 worldwide 45 citations · 25 works
  10. 10 Stephen E. Fawell United States · #285,832 worldwide 138 citations · 36 works
All ranked researchers at AstraZeneca (United States)

Which keywords describe research at AstraZeneca (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Treatment, Inflammation, Epidemiology, Chemotherapy, Targeted Therapy, Clinical Trials, Immunotherapy and Diagnosis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology72▲ 2.5×59 topics
  2. Inflammation58▲ 3.9×59 topics
  3. Treatment50▲ 5.8×21 topics
  4. Chemotherapy40▲ 7.9×21 topics
  5. Diagnosis38▲ 5.7×19 topics
  6. Immunotherapy36▲ 7.1×17 topics
  7. Clinical Trials36▲ 7.5×12 topics
  8. Targeted Therapy35▲ 22×5 topics
  9. Genetics34▲ 6.8×10 topics
  10. Tumor Microenvironment29▲ 9.2×8 topics
  11. Monoclonal Antibodies29▲ 45×3 topics
  12. Asthma28▲ 40×2 topics
  13. Management27▲ 4.8×15 topics
  14. Immunology26▲ 34×2 topics
  15. Prognostic Factors26▲ 8.2×10 topics
  16. Allergic Diseases26▲ 61×1 topic
  17. Eosinophils26▲ 61×1 topic
  18. Glycosylation25▲ 32×3 topics
  19. Therapeutic Antibodies25▲ 50×2 topics
  20. Heart Failure22▲ 7.2×13 topics
  21. Biomarkers22▲ 4.5×14 topics
  22. Breast Cancer22▲ 13×10 topics
  23. Rituximab21▲ 20×4 topics
  24. Lymphoma21▲ 18×3 topics
  25. Cancer Immunotherapy20▲ 18×3 topics
  26. Global Burden20▲ 5.1×7 topics
  27. Cancer Therapy20▲ 4.8×17 topics
  28. Genomic Profiling19▲ 26×2 topics
  29. Precision Medicine19▲ 5.6×7 topics
  30. Treatment Guidelines18▲ 12×4 topics
  31. Chronic Kidney Disease18▲ 10×8 topics
  32. Therapeutic Targets17▲ 16×7 topics
  33. Antibody Engineering16▲ 42×1 topic
  34. Fc Receptors16▲ 42×1 topic
  35. ALK Inhibitors16▲ 36×1 topic
  36. EGFR Mutations16▲ 36×1 topic
  37. Monoclonal Antibody16▲ 43×2 topics
  38. Tumor Regression16▲ 20×2 topics
  39. Immune Checkpoint Blockade15▲ 19×1 topic
  40. PD-1 and PD-L115▲ 19×1 topic

Which research topics does AstraZeneca (United States) publish most on?

By volume in 2022–2025: Asthma and respiratory diseases, Monoclonal and Polyclonal Antibodies Research, Lung Cancer Treatments and Mutations and Cancer Immunotherapy and Biomarkers.

Asthma and respiratory d…26Asthma and respiratory diseases: 26 fractional worksMonoclonal and Polyclona…16Monoclonal and Polyclonal Antibodies Research: 16 fractional worksLung Cancer Treatments a…16Lung Cancer Treatments and Mutations: 16 fractional worksCancer Immunotherapy and…15Cancer Immunotherapy and Biomarkers: 15 fractional worksCAR-T cell therapy research: 14 fractional worksChronic Lymphocytic Leukemia Research: 13 fractional worksChronic Obstructive Pulm…12Chronic Obstructive Pulmonary Disease (COPD) Research: 12 fractional worksCancer Genomics and Diagnostics: 11 fractional worksHER2/EGFR in Cancer Research: 9 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 8 fractional works
PhysiologyRadiology, Nuclear Medicine and ImagingPulmonary and Respiratory MedicineOncology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Asthma and respiratory diseases Physiology 26 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 16 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 16 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 15 works
  5. 5 CAR-T cell therapy research Oncology 14 works
  6. 6 Chronic Lymphocytic Leukemia Research Genetics 13 works
  7. 7 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 12 works
  8. 8 Cancer Genomics and Diagnostics Cancer Research 11 works
  9. 9 HER2/EGFR in Cancer Research Oncology 9 works
  10. 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 8 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.5%not open54.5%

World: 28% of research is openly available.

with international co-authors50.3%domestic only49.7%

World: 19% is written across borders.

How has AstraZeneca (United States)'s research output changed?

Output in 2018–2022 was 31% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Wilmington

All research institutions in Wilmington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.